Gene: FAM234A
Official Full Name: family with sequence similarity 234 member Aprovided by HGNC
Gene Summary: Located in cell surface. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25273 | FAM234A Knockout cell line (HeLa) | Human | FAM234A | 1:3~1:6 | Negative | Online Inquiry |
KO25274 | FAM234A Knockout cell line (HCT 116) | Human | FAM234A | 1:2~1:4 | Negative | Online Inquiry |
KO25275 | FAM234A Knockout cell line (HEK293) | Human | FAM234A | 1:3~1:6 | Negative | Online Inquiry |
KO25276 | FAM234A Knockout cell line (A549) | Human | FAM234A | 1:3~1:4 | Negative | Online Inquiry |
FAM234A Gene Knockout Cell Lines are genetically modified cellular models that have been specifically engineered to lack the FAM234A gene, a critical component involved in various biological processes, including cellular signaling pathways and immune responses. By utilizing CRISPR-Cas9 gene editing technology, these knockout cell lines provide researchers with a robust tool for elucidating the role of FAM234A in diverse cellular phenomena.
The primary function of FAM234A Gene Knockout Cell Lines is to facilitate the study of gene function by allowing scientists to observe the phenotypic consequences of silencing this specific gene. This is achieved through the precise and targeted deletion of the FAM234A gene, which leads to alterations in protein expression and subsequent impacts on cell behavior. Through these alterations, researchers can investigate pathways related to cancer, immunological responses, and various metabolic processes, ultimately contributing to a deeper understanding of disease mechanisms.
The scientific importance of FAM234A Gene Knockout Cell Lines extends to both fundamental research and clinical applications. In research settings, these cell lines enable screening for novel therapies and provide a platform for drug testing, paving the way for potential treatments that could target the pathways influenced by FAM234A. Clinically, insights gained from studies utilizing these knockout models may lead to the development of personalized medicine strategies, particularly for conditions where FAM234A is implicated.
Compared to alternative models, FAM234A Gene Knockout Cell Lines offer several advantages, including high specificity and reproducibility, quick preparation times, and compatibility with a wide array of assays such as Western blotting, RT-PCR, and high-throughput screening. Furthermore, these cell lines are validated for consistent performance across different experimental conditions, making them a reliable choice for researchers.
The value of FAM234A Gene Knockout Cell Lines lies not only in their capabilities as a research tool but also in their potential to accelerate breakthroughs in understanding complex biological systems. Researchers and clinicians alike will find these knockout lines indispensable for advancing their work and uncovering new therapeutic avenues.
At [Your Company Name], we pride ourselves on our cutting-edge genetic engineering technologies and our commitment to providing high-quality biological products. Our expertise in gene manipulation is reflected in the precision and reliability of FAM234A Gene Knockout Cell Lines, making them an exceptional addition to your research toolkit.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.